ArticleMultiple sclerosis and related disorders2021
Reactivation of SARS-CoV-2 after Rituximab in a Patient with Multiple Sclerosis.
Gauruv Bose et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this paperpooled itcites it